The Lancet Oncology
Fecha de publicación: 11 September 2019
Autores: Melina Arnold, PhD., Mark J Rutherford, PhD., Aude Bardot, MSc., Jacques Ferlay, ME., Therese M-L Andersson, PhD
Tor Åge Myklebust, PhD., et al.
Background: Population-based cancer survival estimates provide valuable insights into the effectiveness of cancer services and can reflect the prospects of cure. As part of the second phase of the International Cancer Benchmarking Partnership (ICBP), the Cancer Survival in High-Income Countries (SURVMARK-2) project aims to provide a comprehensive overview of cancer survival across seven high-income countries and a comparative assessment of corresponding incidence and mortality trends.Leer más